Search results for "From ACP Internist"
Diabetes outcomes similar when primary care provided by NPs, PAs, or physicians, study finds
More care by nurse practitioners (NPs) and physician assistants (PAs) may be a way to expand primary care access while maintaining quality standards.
https://diabetes.acponline.org/archives/2018/12/14/10.htm
14 Dec 2018
Weight loss program may improve HbA1c more than typical diabetes nutrition counseling, study finds
Patients participating in Weight Watchers program supplemented with diabetes education lost more weight than a control group by 3, 6, 9, and 12 months of follow-up.
https://diabetes.acponline.org/archives/2016/11/11/8.htm
11 Nov 2016
Once-weekly insulin had similar effects to daily insulin in type 2 diabetes, industry-funded trial finds
HbA1c levels improved by more than a point in insulin-naive patients with inadequately controlled type 2 diabetes who were randomized to a weekly 70-U dose of an investigational insulin.
https://diabetes.acponline.org/archives/2020/10/09/8.htm
9 Oct 2020
Thinking about drug costs and basal insulin in type 2 diabetes
Two articles in the May ACP Internist focused on patients with type 2 diabetes—a cover story explained why and how internists should consider patients' drug costs and the latest Pearls from I.M. Peers talked about basal insulin.
https://diabetes.acponline.org/archives/2022/05/13/7.htm
13 May 2022
New guideline offers recommendations for older patients with diabetes or prediabetes
The Endocrine Society's new clinical practice guideline recommends lifestyle therapy, then metformin, then second-line drugs (but not sulfonylureas and glinides) or insulin for diabetes patients ages 65 years and older, among other advice.
https://diabetes.acponline.org/archives/2019/04/05/6.htm
5 Apr 2019
Canagliflozin may not increase fracture risk in patients at low risk for fractures
Although canagliflozin has been linked to decreased bone mineral density, patients with type 2 diabetes who initiated the drug had similar risk of a first fracture as those who started a glucagon-like peptide-1 receptor agonist.
https://diabetes.acponline.org/archives/2019/01/11/7.htm
11 Jan 2019
Primary care-based weight-loss program led to remission of type 2 diabetes
At the end of 12 months, 36 intervention participants lost 15 kg or more, compared to no participants in the control group, and diabetes remission was associated with the amount of weight lost.
https://diabetes.acponline.org/archives/2018/01/12/11.htm
12 Jan 2018
CGM decreased HbA1c levels, hypoglycemia in patients with type 2 diabetes
Two industry-supported studies of continuous glucose monitoring (CGM) found encouraging results in patients with type 2 diabetes, leading editorialists to call for broadened access to the technology in this population, particularly in primary care.
https://diabetes.acponline.org/archives/2021/06/11/6.htm
11 Jun 2021
ADA, EASD update guidance on managing hyperglycemia
An updated consensus statement from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) addressed social drivers of health, lifestyle modifications, and new drug classes for type 2 diabetes.
https://diabetes.acponline.org/archives/2022/10/14/7.htm
14 Oct 2022
Type of insulin may affect hypoglycemia rates in older adults with type 2 diabetes, study finds
The risk of hospital visits for hypoglycemia was lower with long-acting insulin analogs versus neutral protamine Hagedorn (NPH) insulin in a retrospective study of Medicare patients.
https://diabetes.acponline.org/archives/2021/03/12/8.htm
12 Mar 2021